Polaris AI Pharma Corp. (KOSDAQ:041910)
6,390.00
-320.00 (-4.77%)
At close: May 29, 2026
Polaris AI Pharma Revenue
Polaris AI Pharma had revenue of 14.14B KRW in the quarter ending September 30, 2022, with 0.05% growth. This brings the company's revenue in the last twelve months to 63.94B, up 8.69% year-over-year. In the year 2021, Polaris AI Pharma had annual revenue of 60.40B, down -1.51%.
Revenue (ttm)
63.94B
Revenue Growth
+8.69%
P/S Ratio
1.33
Revenue / Employee
399.60M
Employees
161
Market Cap
84.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 60.40B | -923.01M | -1.51% |
| Dec 31, 2020 | 61.32B | 14.83B | 31.91% |
| Dec 31, 2019 | 46.49B | 6.15B | 15.26% |
| Dec 31, 2018 | 40.34B | 2.12B | 5.55% |
| Dec 31, 2017 | 38.21B | -5.18B | -11.94% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| H.PIO | 258.19B |
| Daehan Nupharm | 205.39B |
| Sinsin Pharmaceutical | 118.65B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 108.89B |
| Hwail Pharmaceutical | 107.87B |
| KOREA PHARMA | 91.42B |
| Sam-A Pharm. | 70.93B |
| GL Pharm Tech | 36.86B |